Abstract
From March to August 2017, 165 measles cases were reported from three regions in Bulgaria. The age range was 0−55 years and 66% of the cases were under 9 years. The Roma population was disproportionally affected (89% of cases), 41% cases were unvaccinated and in 24 cases there was nosocomial transmission mostly in paediatric departments. A child under 12 months of age died. Control measures have been taken and the investigation is still ongoing.
Highlights
Citation style for this article: Kurchatova A, Krumova S, Vladimirova N, Nikolaeva-Glomb L, Stoyanova A, Kantardjiev T, Gatcheva N
We present preliminary findings and the control measures implemented at the beginning of the ongoing measles outbreak
Letters with recommended control measures were provided immediately: general practitioners were requested to check the immunisation status of all persons aged between 13 months and 18 years and to immunise all those unvaccinated with one dose of MMR vaccine; medical specialists in www.eurosurveillance.org hospitals and outpatient settings were requested to be alert to the early detection, timely reporting, isolation, diagnosis, and treatment of measles cases
Summary
Preliminary findings indicate nosocomial transmission and Roma population as most affected group in ongoing measles B3 genotype outbreak in Bulgaria, March to August 2017. A Kurchatova 1 , S Krumova 1 , N Vladimirova 1 , L Nikolaeva-Glomb 1 , A Stoyanova 1 , T Kantardjiev 1 , N Gatcheva 2. Citation style for this article: Kurchatova A, Krumova S, Vladimirova N, Nikolaeva-Glomb L, Stoyanova A, Kantardjiev T, Gatcheva N. Roma population as most affected group in ongoing measles B3 genotype outbreak in Bulgaria, March to August 2017. From March to August 2017, 165 measles cases were reported from three regions in Bulgaria. The Roma population was disproportionally affected (89% of cases), 41% cases were unvaccinated and in 24 cases there was nosocomial transmission mostly in paediatric departments. Control measures have been taken and the investigation is still ongoing
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
